Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    10915095 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults
Conditions: HIV Infections;   Antiretroviral Naive
Interventions: Drug: emtricitabine, FTC (drug);   Drug: didanosine, ddI (drug);   Drug: efavirenz (drug)

Indicates status has not been verified in more than two years